Glaxosmithkline | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
AbbVie USD 700M 90M 2025-03
Amgen USD 694M 29M 2025-06
AstraZeneca 303M 126M 2025-06
Aurora Cannabis CAD 1.29M 768K 2024-12
Bausch Health Companies USD 465M 135M 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Canopy Growth CAD 16.77M 4.51M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Drreddys Laboratories INR 817M 60M 2024-12
Eli Lilly USD 249M 5.3M 2025-06
GlaxoSmithKline 184M 22M 2025-06
Glaxosmithkline 178.05M 24.73M 2024-12
J&J USD 128M 9M 2025-03
Merck USD 305M 8M 2025-06
Novartis USD 289M 19M 2025-06
Pacira USD 3.82M 110K 2025-06
Perrigo 39.6M 600K 2025-06
Pfizer USD 654M 0 2025-06
Prestige Brands USD 10.2M 275K 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 148M 65M 2025-06
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda 107.16B 56.83B 2025-06
Teva Pharmaceutical Industries USD 252M 40M 2025-06
Zoetis USD 53M 1000K 2025-06


Glaxosmithkline Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.